BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11176036)

  • 1. Consensus conference 2000: adjuvant therapy for breast cancer. National Institutes of Health Consensus Development Conference Statement November 1-3, 2000.
    Cancer Control; 2001; 8(1):55. PubMed ID: 11176036
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy for breast cancer. National Institutes of Health Consensus Development Conference Statement.
    Natl Inst Health Consens Dev Conf Consens Statement; 1985; 5(12):5 p.. PubMed ID: 3908920
    [No Abstract]   [Full Text] [Related]  

  • 4. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early breast cancer: adjuvant chemotherapy or radiotherapy, or both?
    Arriagada R
    Acta Oncol; 2006; 45(5):514-6. PubMed ID: 16864163
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Kunkler I
    J Natl Cancer Inst; 2005 Aug; 97(15):1162-3; author reply 1163-4. PubMed ID: 16077078
    [No Abstract]   [Full Text] [Related]  

  • 7. NCCN Task Force Report: Adjuvant Therapy for Breast Cancer.
    Carlson RW; Brown E; Burstein HJ; Gradishar WJ; Hudis CA; Loprinzi C; Mamounas EP; Perez EA; Pritchard K; Ravdin P; Recht A; Somlo G; Theriault RL; Winer EP; Wolff AC;
    J Natl Compr Canc Netw; 2006 Mar; 4 Suppl 1():S1-26. PubMed ID: 16507275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.
    Benchalal M; Le Prisé E; de Lafontan B; Berton-Rigaud D; Belkacemi Y; Romestaing P; Peignaux K; Courdi A; Monnier A; Montcuquet P; Goudier MJ; Marchal C; Chollet P; Abadie-Lacourtoisie S; Datchary J; Veyret C; Kerbrat P
    Cancer; 2005 Jul; 104(2):240-50. PubMed ID: 15948160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant treatment in high-risk breast cancer.
    Jones A
    Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):156-8. PubMed ID: 8777488
    [No Abstract]   [Full Text] [Related]  

  • 11. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Institutes of Health Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer. Editorial overview.
    Lippman ME; Chabner BA
    NCI Monogr; 1986; (1):5-10. PubMed ID: 3534591
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant systemic therapy for breast cancer.
    Harris DT
    Semin Oncol; 1995 Dec; 22(6):553-70. PubMed ID: 8539632
    [No Abstract]   [Full Text] [Related]  

  • 14. Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy.
    Vordermark D; Lackenbauer A; Wulf J; Guckenberger M; Flentje M
    Oncol Rep; 2007 Nov; 18(5):1335-9. PubMed ID: 17914594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer: metastatic.
    Johnston S; Stebbing J
    Clin Evid; 2002 Jun; (7):1579-602. PubMed ID: 12230774
    [No Abstract]   [Full Text] [Related]  

  • 16. More evidence that locoregional radiation therapy improves survival: what should we do?
    Whelan T; Levine M
    J Natl Cancer Inst; 2005 Jan; 97(2):82-4. PubMed ID: 15657332
    [No Abstract]   [Full Text] [Related]  

  • 17. [Radiation and concomitant chemotherapy after surgery for breast cancer].
    Calais G
    Cancer Radiother; 2004 Feb; 8(1):39-47. PubMed ID: 15093200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary chemotherapy in surgically resectable breast cancer: the experience of the Milan Cancer Institute.
    Valagussa P; Bonadonna G
    Zentralbl Gynakol; 1996; 118(10):571. PubMed ID: 8912477
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
    Kim R; Osaki A; Tanabe K; Toge T
    Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does primary chemotherapy really increase the rate of breast conserving treatments?].
    Hennequin C; Espié M; Misset JL; Maylin C
    Cancer Radiother; 2004 Feb; 8(1):48-53. PubMed ID: 15093201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.